GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 74 filers reported holding GAMIDA CELL LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $247,546 | +1178690.5% | 128,262 | +672.6% | 0.00% | – |
| Q4 2022 | $21 | -100.0% | 16,602 | -88.6% | 0.00% | – |
| Q3 2021 | $573,000 | +2.3% | 146,235 | +67.2% | 0.00% | – |
| Q2 2021 | $560,000 | -67.6% | 87,436 | -59.0% | 0.00% | -100.0% |
| Q1 2021 | $1,726,000 | -14.3% | 213,379 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $2,015,000 | +145.1% | 240,119 | +21.2% | 0.00% | 0.0% |
| Q3 2020 | $822,000 | -34.0% | 198,186 | -27.3% | 0.00% | -50.0% |
| Q2 2020 | $1,245,000 | +1331.0% | 272,459 | +848.3% | 0.00% | – |
| Q1 2020 | $87,000 | -42.0% | 28,732 | -17.7% | 0.00% | – |
| Q4 2019 | $150,000 | -49.8% | 34,897 | -49.5% | 0.00% | – |
| Q3 2019 | $299,000 | -48.8% | 69,077 | -39.9% | 0.00% | -100.0% |
| Q2 2019 | $584,000 | +167.9% | 115,010 | +505.4% | 0.00% | – |
| Q1 2019 | $218,000 | +3.8% | 18,996 | -9.9% | 0.00% | – |
| Q4 2018 | $210,000 | – | 21,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
| Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
| Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
| Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
| Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
| FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
| Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
| PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |